|
| Henry S Friedman | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Michael D Prados | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Michael D Prados | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Patrick Y Wen | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Tom Mikkelsen | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Tom Mikkelsen | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Wai-Kwan Alfred Yung | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Wai-Kwan Alfred Yung | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Timothy F Cloughesy | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |
| Timothy F Cloughesy | Duke University, University of California, Los Angeles School of Medicine, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Henry Ford Hospital, University of Virginia, Memorial Sloan-Kettering Cancer Center, M. D. Anderson Cancer Center, University of Chicago, IL and University of Utah Hospital |